04:02 PM EDT, 04/09/2025 (MT Newswires) -- Health care stocks rose late Wednesday afternoon, with the NYSE Health Care Index adding 3.3% and the Health Care Select Sector SPDR Fund (XLV) up 4.3%.

The iShares Biotechnology ETF (IBB) climbed 5.7%.

In corporate news, Anixa Biosciences ( ANIX ) shares surged past 12% after the company said it received a notice of allowance from the US Patent and Trademark Office for its breast cancer vaccine technology.

Bristol-Myers Squibb ( BMY ) shares rose 1.7%. The company won the dismissal of a proposed class-action lawsuit in a federal court accusing it of using anticompetitive tactics to maintain monopoly on its blood cancer drug Pomalyst, media outlets reported.

Microbot Medical ( MBOT ) shares jumped 20%. The company said that robotic endovascular procedures using its Liberty system are feasible and significantly minimize radiation exposure, based on data from a study.

Neogen (NEOG) shares slumped 29% after fiscal Q3 adjusted earnings and revenue fell, and the company cut full-year revenue guidance. Neogen also said Chief Executive Officer John Adent will step down.